Training Opportunities

Main Content

ZOOMing in on Preeclampsia Virtual Seminar Series

The seminar series will provide training and networking opportunities for early stage investigators and trainees that are engaged in preeclampsia research.  This is a weekly event hosted by Dr. Joey Granger, Dr. Ananth Karumanchi, or Dr. Sarosh Rana and sponsored by the Preeclampsia Foundation and the Cardiovascular-Renal Research Center at University of Mississippi Medical Center.
The format of the seminar includes two- 20 min presentations: one basic science presentation and one clinical or population presentation.   We will also have three 12 min presentations by trainees every other Monday at 12:00 PM CST.
If you or your colleagues are interested in participating and/or presenting at this virtual seminar series, please fill out the following google document:
  • 11/16/2020 - "Angiogenic Biomarkers for Risk Stratification of Women with Preeclampsia," Sarosh Rana, MD, MPH, FACOG, Professor of Obstetrics and Gynecology, Section Chief of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The University of Chicago and "Developig Maternally Sequestered Biologics for Treatment of Preeclampsia," Gene L. Bidwell, Phd, Associate Professor of Neurology, Univeristy of Mississippi Medical Center
  • 11/23/2020 - "Mechanisms of Microvascular Dysfunction following Preeclampsia," Anna Stanhewicz, PhD, Assistant professor of Health and Human Physiology, University of Iowa and "Incidence of Postpartum Hypertension within 2 Years of a Pre-clamptic Pregnancy:  A Systematic Review and Meta-analysis," Veronica Giorgione, PhD, Postdoctoral fellow, St. Georges, Univeristy of London and Establishment of a Novel Flow Culture System to Decipher the Etiology of Preeclampsia, Laura Ormesher, MRC Clinical Research Fellow, Division of Developmental Biology and Medicine, University of Manchester, UK
  • 11/30/2020 - "What does the Brain and Urine Have to Do With It?," Mark Santillan, MD, PhD, FACOG, FAHA, Associated professor, Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine and "If We Know so much about Preeclampsia, Why Haven't We Cured It,?" James Roberts, MD, Professor of Obstetrics Gynecology and Reporductive Sciences, Epidemiology, and Clinical and Translational Research, University of Pittsburgh
  • 12/7/2020 - "Postpartum Neurovascular Complications following Placnetal Ischemia," Junie Paula Warrington, PhD, Assistant Professor, Department of Neurology, University of Mississippi Medical Center and "Short-term Self-Management of Blood Pressure Post-partum and its Long-term Impact on Blood Pressure Trajectory," Jamie Kitt, MD, PhD, British heart Foundation Clinical Research Fellow, Univeristy of Oxford, UK and "eQTL Analysis in the Human Placenta," Clara Apicella, MS, PLACENTA H2020, Institute Cochin, INSERM U1016, Paris, France
  • 12/14/2020 - "What Science is All About: Falsifying a Hypothesis," Berthold Huppertz, PhD, Chair, Department of Cell Biology, Histology, and Embryology Gottfried Schatz Research Center, Medical University of Graz, Austria and "Role of PIGF in Preeclampsia," Ananth Karumanchi, MD, Medallion Chair in Vasculat Biology, Director of Nephrology, Cedars Sinai
  • 1/11/2021 - "A Dormant Microbial Component in the Development of Preeclampsia, and the Potential Role of Ergothioneine," Douglas Kell, PhD, Research Professor in Systems Biology, University of Liverpool, UK and "MXe786, a Hydrogen Sulfide Releasing Aspirin Prevents Preeclampsia in Heme Oxygenase-1 Haplodeficient Pregnancy Under High Soluble Flt-1 Environment," Asif Ahmed, PhD, Executive Chairman and CEO, MirZyme Therapeutics, Birmingham, UK
  • 1/18/2021 - "Uromodulin in a Rodent Model of Hypertensive Pregnancy," Sheon Mary, PhD, Research Associate, Institute of Cardiovascular and Medical Sciences, University of Glasgos, UK and "Adrenergic Receptors Mediating the Blood Pressure Response to Placental Ischemia-induced Hypertension," Frank Spradley, PhD, Assistant Professor, Director of Basic Science Research, Department of Surgery, University of Mississippi Medical Center and "Establishment of Novel Flow Culture System to Decipher the Etiology of Preeclampsia, Nadja Kupper, MSc, PhD student, Department of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria
  • 1/25/2021 -  No Seminar
  • 2/1/2021 -  "From ASPRE to FIGO: Implementationof First Trimester Prediction and Prevention of Preeclampsia," Liona Poon, MD, Professor, Department of Obstetrics and Gynecology, the chinese Unversity of Hong Kong and "Implementation of Routie First Trimester Combined Screening for Preeclampsia: a Clinical Effectiveness Study
  • 2/8/2021 "Systemic Reviews and Meta-analysis Across Species: Can it Help Us to Design Better Trials?," Titia Lely, MD, PhD, Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Center Utrech, Netherlands and "Alternative Splicing in Normal and Pathological Human Placentas is Correlated to Genetic Variants," Daniel Vaiman, PhD, Research Director, Cochin Institute, INSERM, Paris, France
  • 2/15/2021 - "BH4 as a Therapeutic Target in Preeclampsia and Associated Long-term Vascular Risk," Keith Channon, PhD, University of Oxford, UK and "Inflammation and Autoantibodies Produced during Preeclampsia: Novel Therepeutics Targets for an Old Disease," Birdie Lamarca, PhD, Professor, Deparmtent of Pharmacology and Obstetrics and Gynecology, University of Mississippi Medical Center
  • 2/22/2021 - "Maternal Interventions in a Rat Model of PE, Do Benefits in the Mother Translate to Benefit Versus Harm in the Offspring?," Barbara Alexander, PhD, FAHA, FAPS, Professor, Department of Physiology and Biophysics, Director, Analytical and Assay Laboratory, University of Mississippi Medical Center and "Educating Immune Cells Pathway Lowers Preeclampsia Risk," Francesco Colucci, MD, PhD, Department of Obstetrics and Gynaecology, University of Cambridge Clinical School
  • 3/1/2021 - "Hydoxychloroquine effect on fetoplacental endothelial activation in vitro," Maja Gajic, MSc, PhD student, Department of Obstetrics and Gynecology, Medical University of Graz, Austria and "CITED2 Regulates Placental Development and Adaptations to Environmental Stressors," Marija Kuna, PhD, Postdoctoral Fellow, University of Kansas Medical Center and "Potential Mechanisms of Placental Microvascular Dysfunction," Jennifer McIntosh, DO, MS,Associate Professor of OB-GYN, Medical College of Wisconsin
  • 3/8/2021 - "Syncytiotrophoblast Stress," Christopher Redman MB, BChir, FRCP, FRCOG Professor Emeritus, University of Oxford, UK and "Circulating syncytiotrophoblast microvesicles," Manu Vatish, MBBCh BA,DPhil MA, MRCOG, Senior Clinical Fellow, University of Oxford. UK
  • 3/15/2021 - "Investigating potential mechanisms for increased seizure susceptibility in RUPP mice," Maria Jones-Muhammad, Graduate Student, Department of Neurology, University of Mississippi Medical Center and "Preeclampsia Today," Manurishi Nanda, Clinical Fellow Medical University of Graz, Austria
  • 3/22/2021 - "Novel Biomarkers of Pre-eclampsia," Nita J Maihle, PhD, Associate Cancer Center Director Professor or Medicine, Cell & Molecular Biology, University of Mississippi Medical Center and "The Kynurenine pathway: could it be a future treatment for hypertension in pregnancy?," Stephanie Worton, Academic Clinical Lecturer, Clinical Scientist, Division of Developmental Biology and Medicine, University of Manchester, UK
  • 3/29/2021 - "The Role of Kisspeptins in Preeclampsia:  Translational Studies using the Preeclamptic-like BPH/5 Mouse," Viviane Gomes, DVM, Diplomate American College of Theriogenologists, Theriogenology Resident & PhD student, Louisiana State University
  • 4/5/2021 - "Placentation in preeclampsia predicts cardiovascular risk in offspring," Kent Thornburg, PhD, Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health and Science University
  • 4/12/2021 - "Impact of preeclampsia on cardiac and vascular development in the offspring," Adam Lewandowski, DPhil, University Research Lecturer, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK
  • 4/19/2021 - "Novel therapeutics for pre-eclampsia," Cathy Cluver, PhD, Associate Professor, Department of Obstetrics and Gynaecology & Perinatolist, PI Research Team Leader, Stellenbosch University, Cape Town, South Africa and "Placental pathology of preeclampsia: what we learned from decidual vasculopathy," Peilin Zhang, MD, PhD, Placental and Perinatal Pathologist, NY Presbyterian Brooklyn Methodist Hospital
  • 5/3/2021 - "The Role of Tocotrienol in Preeclampsia Prevention," Zaleha Abdullah Mahdy, PhD, Professor of Obstetrics and Gynaecology, the National University of Malaysia
  • 5/10/2021 - "Fecal microbiome in the offspring of BPH/5, a preeclamptic-like mouse model," Kalie Beckers, DVM, PhD student, Department of Veterinary Clinical Sciences, Louisiana State University and "Exploring mechanisms of cardiovascular disease after experimental preeclampsia," Lauren Biwer, PhD, Postdoctoral Research Associate, Molecular Cardiology Research Institute, Tufts Medical Center
  • 5/17/2021 - "Angiogenic factors to predict preeclampsia-related adverse outcomes in the clinical routine," Stefan Verlohren, MD, PhD, Professor of Obstetrics, Charité –Universitätsmedizin Berlin, Germany

MCCTR and COBRE Joint Seminar Series

The MCCTR Seminar Series offers monthly seminars as a forum for the presentation of high-impact obesity-related research and as an opportunity for junior investigators to present their research and receive feedback. The MCCTR works closely with the Mississippi Center for Obesity Research and the Cardiorenal and Metabolic Diseases Research Center to promote the series and to accommodate campus visits by accomplished scientists. In addition, seminars are broadcast widely to our partner institutions. To date, the MCCTR and COBRE have collaborated to provide over 30 seminars the research population at UMMC and our partner institutions.

Upcoming seminars and seminars from our current fiscal year are listed below. If you would like to receive notifications of seminar dates and/or a link view a seminar remotely, contact

MCCTR and COBRE Work in Progress Meetings

The main goal of the COBRE-MCCTR "Workin Progress" Meetings is to help oinvestigators advance their research programs and prepare for submission of extramural grant applications. 

These meetins focus on new research ideas, specific aims of investigators' projects, updates of research progress, and new research methods/technologies. Meetings are held monthly and generally feature two short presentations (15 minutes each) by clinical and translational researchers as well as basic scientists, followed by substantial discussions aimed at critiquing and advancing the research projects.

All members of the MCCTR and COBRE as well as any other investigators who are interested in the discussion topics are invited.  Members of the Internal and External Advisory Boards are also invited to join the dicussions which will be video conferenced.